ACST.V
Price:
$0.58
Market Cap:
$48.97M
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Industry
Biotechnology
IPO Date
2011-03-31
Stock Exchange
TSXV
Ticker
ACST.V
According to Acasti Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.07. This represents a change of -33.49% compared to the average of -1.61 of the last 4 quarters.
The mean historical PE Ratio of Acasti Pharma Inc. over the last ten years is -0.86. The current -1.07 PE Ratio has changed 12.33% with respect to the historical average. Over the past ten years (40 quarters), ACST.V's PE Ratio was at its highest in in the March 2025 quarter at 12.29. The PE Ratio was at its lowest in in the September 2025 quarter at -12.65.
Average
-0.86
Median
-0.45
Minimum
-2.88
Maximum
-0.08
Discovering the peaks and valleys of Acasti Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual PE Ratio = -0.08
Minimum Annual Increase = -71.98%
Minimum Annual PE Ratio = -2.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.88 | 65.40% |
| 2024 | -1.74 | 230.15% |
| 2023 | -0.53 | -71.98% |
| 2022 | -1.88 | 397.98% |
| 2021 | -0.38 | 81.82% |
| 2020 | -0.21 | 80.10% |
| 2019 | -0.12 | 35.92% |
| 2018 | -0.08 | -56.25% |
| 2016 | -0.19 | -69.14% |
| 2015 | -0.63 | 1.02% |
The current PE Ratio of Acasti Pharma Inc. (ACST.V) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.72
5-year avg
-1.48
10-year avg
-0.86
Acasti Pharma Inc.’s PE Ratio is less than Aeterna Zentaris Inc. (-0.36), less than Think Research Corporation (-0.74), less than MedMen Enterprises Inc. (-0.00), less than Reunion Neuroscience Inc. (-0.34), less than Greenbrook TMS Inc. (-0.03), greater than HS GovTech Solutions Inc. (-3.29), less than IMV Inc. (-0.18), greater than Vinergy Capital Inc. (-10.12), less than YourWay Cannabis Brands Inc. (-0.00), less than IBEX Technologies Inc. (9.23),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.36 | $25.38M | |
| -0.74 | $24.82M | |
| -0.00 | $27.66M | |
| -0.34 | $16.64M | |
| -0.03 | $28.55M | |
| -3.29 | $29.01M | |
| -0.18 | $13.12M | |
| -10.12 | $20.18M | |
| -0.00 | $22.94M | |
| 9.23 | $35.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acasti Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acasti Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acasti Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Acasti Pharma Inc. (ACST.V)?
What is the highest PE Ratio for Acasti Pharma Inc. (ACST.V)?
What is the 3-year average PE Ratio for Acasti Pharma Inc. (ACST.V)?
What is the 5-year average PE Ratio for Acasti Pharma Inc. (ACST.V)?
How does the current PE Ratio for Acasti Pharma Inc. (ACST.V) compare to its historical average?